Ana C. Xavier

<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang et al. · Clinical Cancer Research · 2007 · 598 citations · Full text

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Fred R. Hirsch, Marileila Varella‐Garcia, Jason McCoy et al. · Journal of Clinical Oncology · 2005 · 584 citations · Full text

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo et al. · Annals of Oncology · 2007 · 270 citations · Full text

Oncology, Protein Expression, Medicine +6

Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas

Ximing Tang, Marileila Varella‐Garcia, Ana C. Xavier et al. · Cancer Prevention Research · 2008 · 102 citations · Full text

R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis

Nirav N. Shah, Anikó Szabó, Scott F. Huntington et al. · British Journal of Haematology · 2017 · 96 citations · Full text